16:02 Dec 20
Suven Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Suven Pharmaceuticals Ltd.
54/100 Medium Financial Strength
Quality9/100 Expensive Valuation
Valuation55/100 Technically Neutral
TechnicalSWOT
Strength
6
Weakness
9
Opportunity
1
Threat
1
30.17K
Market Cap (Cr)
124.10
PE Ratio
15.25
Price to Book Ratio
28.6
RSI
28.56 %
Net Profit Margin
Rating Based on 1 Analysts
Buy
0%
Hold
0%
Sell
100%
Sell
Analyst Price Target
The average price target is 571 with a high estimate of 571 and low estimate of 571
Current 1185.15
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
